Dosage FormPowder for suspension for injection
Strength25 mg/ml
Strength per Unit100 mg, 150 mg
ATC Code L01BC07
Drug ClassAntineoplastic agents, pyrimidine analogues
IndicationAzacitidine is indicated for the treatment of adult patients who are not eligible for haematopoietic stem
cell transplantation (HSCT) with:
− intermediate-2 and high-risk myelodysplastic syndromes (MDS) according to the International
Prognostic Scoring System (IPSS),
− chronic myelomonocytic leukaemia (CMML) with 10–29 % marrow blasts without
myeloproliferative disorder,
− acute myeloid leukaemia (AML) with 20–30 % blasts and multi-lineage dysplasia, according to
World Health Organisation (WHO) classification,
− AML with > 30 % marrow blasts according to the WHO classification.

Azacitidine EVER Pharma is a prescription medication. Information for healthcare professionalsationen nur für medizinisches Fachpersonal.
See the Summary of Product Characteristics for full information about the medication.